Arvaya Healthcare corrects shareholding data in postal ballot notice

Arvaya Healthcare Limited has issued a corrigendum to its postal ballot notice dated July 13, 2026, correcting the post-issue shareholding percentage of Mr. B. K. Anilkumar to 4.45% from the previously stated 4.81%. The company also introduced a special resolution proposing enhanced lock-in requirements for 14 non-promoter shareholders allotted equity shares for the acquisition of Sushodha Institute of Gastroenterology Private Limited. The modifications aim to align shareholder interests with the company's long-term growth by ensuring continued engagement from distinguished medical professionals.

The corrigendum confirms that Mr. B. K. Anilkumar is a non-promoter. The revised shareholding calculation is based on 2,312,002 shares against a total of 51,893,711 shares. The company has proposed a tiered lock-in structure for the new allottees, exceeding the minimum requirements mandated by the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Lock-in Structure for Allottees

The resolution specifies that 40% of the equity shares allotted to certain shareholders shall be locked-in for three years, 40% for two years, and 20% for one year from the date of allotment. The allottees include medical professionals such as J K Pradeepkumar, B K Anilkumar, and Sanjeev V Chintamani.

Name of the Proposed Allottee	Category	No. of Equity Shares	Lock-in Requirement
J K Pradeepkumar	Non-Promoter	1328124	40% locked-in for 3 years
B K Anilkumar	Non-Promoter	591129	40% locked-in for 3 years
Rudresh Tabali	Non-Promoter	63273	40% locked-in for 2 years
Sapan D S	Non-Promoter	12663	20% locked-in for 1 year
Sanjeev V Chintamani	Non-Promoter	63273	20% locked-in for 1 year

Shareholders who have already cast their votes prior to the receipt of this corrigendum may modify their votes by emailing the scrutinizer, Mr. Chinmay Mohan Lele, at chinmayele2804@gamil.com on or before August 13, 2026. The e-voting period, which commenced on July 15, 2026, is scheduled to conclude on August 13, 2026, with results to be declared on August 17, 2026.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.00%	-0.90%	+86.74%	+150.15%	+444.84%	+495.38%

Bijoy Hans Ltd will change its name to Arvaya Healthcare Limited effective July 13, 2026. BSE Limited has approved the application and recorded the new name, along with the Scrip ID ARVAYA for the BOLT Plus system. The change follows a prior disclosure submitted to the exchange on May 12, 2026.

The exchange issued a notice confirming the alteration in the company's identity and trading identifiers. The abbreviated name on the BOLT Plus System will also be updated to ARVAYA. This modification impacts the company's listing records and trading parameters on the exchange.

Change in Trading Details

The following table outlines the specific changes to the company's scrip details:

Scrip Code	Existing Name	New Name	Scrip ID for BOLT Plus System	Abbreviated name on BOLT Plus System
524723	Bijoy Hans Ltd	Arvaya Healthcare Limited	ARVAYA	ARVAYA

The approval was communicated by Marian Dsouza, Assistant Vice President - Listing Compliance & Operations at BSE Limited. The company's Managing Director, Kaushal Shah, signed the disclosure confirming the effective date of the name change.